China's State Council on Friday pledged to press ahead with addressing wage arrears for migrant workers to safeguard their legitimate rights and interests.
The pledge was made at a meeting presided over by Chinese Premier Li Keqiang.
Attendees of the meeting said that addressing the issue of wage arrears for migrant workers was an important step to increase their income and strengthen social justice, embodying the people-centered development concept.
The State Council will carry out special campaigns and inspection tours to crack down on such offenses, while making some cases public.
Provincial, municipal and county-level officials will be held accountable for wage arrears for migrant workers within their jurisdictions, according to the meeting.
Human resources and social security departments must maintain clear and open channels for people to report crimes, and a blacklist system should be created to punish enterprises which are in arrears with migrant workers' salaries.
Attendees also agreed to handle lawmakers' suggestions and political advisors' proposals to promote scientific decision making. They said handling lawmakers' suggestions and political advisors' proposals are important for addressing people's concerns and advancing administration according to law.
In 2016, departments of the State Council handled 7,873 national lawmakers' suggestions and 3,862 proposals by national political advisors, and more than 3,000 opinions and suggestions were taken into consideration when drafting relevant policies and regulations.
Attendees vowed to further address suggestions and proposals this year, strengthening communication with lawmakers and political advisors, and making public all responses to suggestions and proposals.
The 13th Five-Year Plans on food and drug safety were both approved at the meeting. According to the plans, local governments, particularly county-level governments, must be responsible for ensuring food safety. Firm crackdowns will be launched against illegal additives to prevent risks.
The authenticity of clinical test data on drugs will be put under closer watch, and production and sales of counterfeit drugs will be severely punished.
Sample tests and early warning will be boosted, and such tests must cover food, blood products, vaccines and essential medicines.
Moreover, technology such as big data must be harnessed to ensure food and drug safety, and national standards for medicines, medical equipments as well as cosmetics must be heightened.
